Correction: Dal Monte et al. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267
Massimo Dal Monte, Maurizio Cammalleri, Rosario Amato, Salvatore Pezzino, Roberta Corsaro, Paola Bagnoli, Dario Rusciano
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCircadian rhythm and melatonin · Nicotinic Acetylcholine Receptors Study · Neurological Disorders and Treatments
In the original publication [1], there was a mistake in Figure 7 as published. During the preparation of the manuscript, a draft copy of the figure was inadvertently uploaded instead of the finalized figure intended for publication. The authors apologize for this inconvenience. The corrected Figure 7 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Dal Monte M. Cammalleri M. Amato R. Pezzino S. Corsaro R. Bagnoli P. Rusciano D. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma Int. J. Mol. Sci.202021926710.3390/ijms 2123926733291737 PMC 7730513 · doi ↗ · pubmed ↗